The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with ...

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections Inspira announced its bio-electronic ...

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia Troriluzole has a well-established safety profile and if ...

Non-CGRP assets including troriluzole for obsessive compulsive disorder and spinocerebellar ataxia and verdiperstat for amyotrophic lateral sclerosis will transfer to Pfizer's internal pipeline.

After hours: February 14 at 7:57:59 PM EST ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the formation of ALS United, global sleep study results from IKEA and FDA approval of EMBLAVEOtm.

After hours: 7:57:59 pm GMT-5 ...